Yuko Mizuma – GM, Hong Kong & Macau, Eli Lilly Asia, Inc.
Yuko Mizuma, general manager of Hong Kong and Macau at Eli Lilly Asia, Inc., shares her impressions of Hong Kong’s healthcare ecosystem after working in Japan and the US, discusses…
MediConcepts was founded with the aim to provide the optimized solutions for medical device design development and manufacturing to a wide range of customers whether they are innovators who need a compliant product development process and collaboration; or projects seeking for a reliable high quality mass production with complete traceability.
Early projects that MediConcepts encountered include redeveloping a two hand operated intra-ocular lens disposable case to an one hand operated casing in late 90’s; and a minimal invasive tissue retrieval system originated from a UK surgeon who is also a pioneer in minimal access surgery in early 2000’s. The design briefs were simply a hand-sketched drawing faxed to us and we delivered a complete design and production in less than 6 months. Since then, our philosophy has been focusing on “design by surgeon for surgeons” medical devices.
The range of products that we now cover are very broad. “Think Medical” is our believe and “Redefine the medical device Contract Manufacturing Experience” is what we want to offer to our customers. Eventually, we want to position MC to be the ideal CM.
Contact
Address 7A-D Hong Kong Industrial Building, 444-452 Des Voeux Road West, Hong Kong
Tel: +852 2838 0300
Website: http://www.mediconcepts.com/
Email: marketing@mediconcepts.com
Yuko Mizuma, general manager of Hong Kong and Macau at Eli Lilly Asia, Inc., shares her impressions of Hong Kong’s healthcare ecosystem after working in Japan and the US, discusses…
Drawing on an extensive management background in telecom, IT, and digital, Vincent Ma now serves as CEO of the Hong Kong-Shenzhen Innovation and Technology Park (HSITP). He outlines the under-construction…
Johnson & Johnson Innovative Medicine veteran and general manager of the company’s Hong Kong & Macau affiliate SunKeun Huh explains J&J Hong Kong’s strong position in schizophrenia and its significant oncology…
OASES was established to position Hong Kong as a global innovation and technology hub, with significant investments in infrastructure and funding, particularly focusing on life and health sciences, AI, fintech,…
One year since our last conversation, the Hong Kong Institute of Biotechnology’s Gina Jiang introduces the significant strides made in setting up a GMP facility for CAR-T cell therapy manufacturing…
A surgeon by training, Prof Philip Chiu is now dean of the Faculty of Medicine at the research-focused Chinese University of Hong Kong (CUHK). He shares the creation of CUHK’s…
The City University of Hong Kong (CityUHK) has a well-earned reputation as an innovative hub for research and professional education. Michael Yang, Senior VP of Innovation and Enterprise, professor of…
Andrea Chang, general manager of Eisai Hong Kong explains the importance of the firm’s FDA-approved Biogen-partnered Alzheimer’s disease (AD) product, particularly in Hong Kong where some 20 percent of the…
Dr Juliana Chan, one of Asia’s leading endocrinologists, is also the founding director of GemVCare, a company that provides data to medical professionals to advise patients on diabetes prevention, diagnosis, and…
Immuno Cure has a unique approach to the failure-ridden field of HIV vaccine development: focusing on a therapeutic vaccine for already infected individuals rather than a preventive vaccine. Founders Tom…
Arbele is a clinical stage biotech centred on an innovative T-Cell Engager approach to gastrointestinal cancers. Chairman and founder John Luk explains the prevalence of these cancers in China, the…
Sabrina Chan, senior executive director of the Hong Kong Association of the Pharmaceutical Industry (HKAPI), an organization that represents the innovative pharmaceutical industry in Hong Kong and Macau, weighs in…
See our Cookie Privacy Policy Here
